Clinical Trial News and Research

RSS

Non-Caucasians at higher risk for severe metastatic breast cancer pain

A new study finds significant racial differences in the risk of pain related to metastatic breast cancer.

26 Nov 2007

Major clinical trial of osteoporosis screening begins

Researchers are looking for local women in the Weston/North Somerset area over the age of 70 to take part in the second phase of a major clinical trial to find out if screening older women for osteoporosis can help to reduce the numbers who suffer bone fractures.

26 Nov 2007

Potential link between congenital heart anomaly and migraines

Interventional cardiologists at Rush University Medical Centerare investigating whether a heart procedure may be the key to relieving migraines in patients with severe headaches.

21 Nov 2007

FDA clears Veridex test for the monitoring of metastatic colorectal cancer

Veridex, LLC has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.

21 Nov 2007

Affiris GmbH granted a Europe-wide patent for key elements of its Alzheimer's vaccine

As a result, the company has exclusive rights of use to the peptide sequences for an innovative approach to vaccine development. The tolerability of the first Affiris vaccine, AFFITOPE AD01, is currently being tested as part of a phase I clinical trial. The lead investor in the company, MIG-Fonds, is extremely satisfied with the expanding patent portfolio of Affiris GmbH.

21 Nov 2007

Dyslexia expert Dr. Bruce McCandliss awarded Presidential honor

Dr. Bruce McCandliss, a psychologist at the Sackler Institute for Developmental Psychobiology and associate professor of psychology in psychiatry at Weill Cornell Medical College, has received a commendation by the President of the United States in the form of a Presidential Early Career Award for Scientists and Engineers (PECASE).

20 Nov 2007

Tonsillectomy may increase costs without benefits in some children

A Dutch study suggests that among children with mild or moderate symptoms of throat infections, surgery to remove the tonsils may be more expensive but not necessarily more beneficial than watchful waiting, according to a report in the November issue of Archives of Otolaryngology-Head & Neck Surgery.

20 Nov 2007

Gene-transfer technique trial for childhood blindness under way

Three decades have passed since gene therapy pioneer William W. Hauswirth, Ph.D., and his colleagues at the University of Florida began work on a virus that could safely deliver corrective genes into living animals.

19 Nov 2007

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable.

19 Nov 2007

NewYork-Presbyterian/Weill Cornell opens new section of general surgery called Gastrointestinal Metabolic Surgery

Opening the doors to one of the first academic medical program dedicated to surgical treatment of type 2 diabetes, NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created a new section of General Surgery called Gastrointestinal Metabolic Surgery.

19 Nov 2007

MIT researchers devised novel way to create tiny colonies of living human liver cells that model full-sized organs

Liver toxicity is one of the main reasons pharmaceutical companies pull drugs off the market. These dangerous drugs slip through approval processes due in part to the shortcomings of liver toxicity tests. Existing tests rely on liver cells from rats, which do not always respond to toxins the way human cells do. Or they rely on dying human cells that survive for only a few days in the lab.

19 Nov 2007

Block buster cancer drug Avastin gives hope to brain tumor victims

According to a new study the blockbuster cancer drug Avastin has shown promising results in treating brain cancer victims.

19 Nov 2007

How inhibitor-of-apoptosis chemicals kill tumors

Chemical compounds specially designed to neutralize proteins that would otherwise allow tumor cells to cheat death have been recognized for some time by scientists as a promising new avenue for cancer therapy.

16 Nov 2007

Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia

Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), today announced positive results from Trial CL-05, the second of two pivotal phase III clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day oral antibiotic for the treatment of mild-to-moderate community acquired pneumonia (CAP), the sixth leading cause of death in the United States.

16 Nov 2007

GlaxoSmithKline implements changes to the US product label for Avandia

GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial ischemia data on Avandia, the most widely studied oral anti-diabetic medicine available.

15 Nov 2007

Petition aims to stem the flood of dangerous drugs reaching Americans

In a petition filed with the U.S. Food and Drug Administration, an international coalition of scientists and doctors seeks to compel the agency to stem the flood of dangerous drugs reaching American consumers by mandating the use of scientifically superior non-animal testing methods when those alternatives exist.

15 Nov 2007

Understanding diversity in disease - new routes to prevention, diagnosis and treatment

The Medical Research Council (MRC), the National Institute for Health Research (NIHR) and the health research departments in Northern Ireland, Scotland and Wales have launched a joint initiative of more than £6millon to identify small carefully defined groups of patients to help researchers detect, treat or prevent diseases.

14 Nov 2007

Sanofi Pasteur and Acambis to bring West Nile vaccine to market

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive global collaboration agreement with Acambis plc, for the development and marketing of a West Nile vaccine to help fight against this serious, life-altering and potentially fatal disease.

14 Nov 2007

Hope on the horizon for hereditary angioedema sufferers

Although there is currently no treatment approved by the Federal Drug Administration (FDA) for acute attacks of hereditary angioedema (HAE) - a genetic disease causing swelling of extremities, face and internal organs that can be life-threatening - hope is on the horizon according to a team of experts presenting the latest research at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Dallas.

14 Nov 2007

Smoking cessation during pregnancy is focus of study

Despite warnings from experts and media campaigns marketing healthy living techniques, approximately one-third of women of childbearing age smoke cigarettes and 25-50 percent of women smoke during pregnancy.

13 Nov 2007